Paloma Fernández-Pacheco López-Amor

Paloma Fernández-Pacheco López-Amor

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
MPMiriam Pedrera
Miriam Pedrera
ASAlejandro Soler
Alejandro Soler
ASAlicia Simón
Alicia Simón
NCNadia Casado
Nadia Casado
CPCovadonga Pérez
Covadonga Pérez
Carmina Gallardo FrontauraCarmina Gallardo Frontaura
Carmina Gallardo Frontaura
Candidate vaccines against African swine fever virus (ASFV) based on naturally attenuated or genetically modified viruses have the potential to generate protective immune responses, although there is no consensus on what defines a protective immune response against ASFV. Studies, especially in sensitive host species and focused on unravelling protective mechanisms, will contribute to the development of safer and more effective vaccines. The present study provides a detailed analysis of phenotypic and functional data on cellular responses induced by intradermal immunization and subsequent boosting of domestic pigs with the naturally attenuated field strain Lv17/WB/Rie1, as well as the mechanisms underlying protection against intramuscular challenge with the virulent genotype II Armenia/07 strain. The transient increase in IL-8 and IL-10 in serum observed after immunization might be correlated with survival. Protection was also associated with a robust ASFV-specific polyfunctional memory T-cell response, where CD4CD8 and CD8 T cells were identified as the main cellular sources of virus-specific IFNγ and TNFα. In parallel with the cytokine response, these T-cell subsets also showed specific cytotoxic activity as evidenced by the increased expression of the CD107a degranulation marker. Along with virus-specific multifunctional CD4CD8 and CD8 T-cell responses, the increased levels of antigen experienced in cytotoxic CD4 T cells observed after the challenge in immunized pigs might also contribute to controlling virulent infection by killing mechanisms targeting infected antigen-presenting cells. Future studies should elucidate whether the memory T-cell responses evidenced in the present study persist and provide long-term protection against further ASFV infections.

13 February 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
DRDavid Romero-Trancón
David Romero-Trancón
MVMarta Valero-Lorenzo
Marta Valero-Lorenzo
MRM.José Ruano
M.José Ruano
PLPaloma Fernández-Pacheco López-Amor
Paloma Fernández-Pacheco López-Amor
EGElena García-Villacieros
Elena García-Villacieros
RVRuben Villalba
Ruben Villalba
Bluetongue is an infectious, non-contagious, arthropod-borne viral disease of ruminants caused by bluetongue virus (BTV), producing severe impacts on livestock. Historically, Southern Europe has suffered multiple incursions of different BTV serotypes with serious consequences. In 2021, BTV re-emerged in the Balearic Islands (Spain) after 16 years free of the disease, causing a large outbreak that mainly affected sheep, as well as cattle and goats. A novel emerging strain of BTV serotype 4 (BTV-4) was identified via preliminary molecular characterization as the etiological culprit of the epizootic. This study delineates the outbreak in the Balearic Islands in 2021, encompassing field-based clinical observations and laboratory findings. Additionally, an experimental infection was conducted in sheep using the novel BTV-4 strain to assess its virulence, pathogenicity, and laboratory diagnostic characteristics. The in vivo characterization was conducted concurrently with the virulent and widely disseminated BTV-4 RNM 2020 strain that has precipitated significant outbreaks in the Mediterranean region in recent years. Both strains exhibited analogous pathogenic potential in sheep and yielded equivalent outcomes in diagnostic parameters. Furthermore, the impact of the novel BTV-4 strain is discussed.

7 March 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
MPMiriam Pedrera
Miriam Pedrera
ASAlejandro Soler
Alejandro Soler
ASAlicia Simón
Alicia Simón
NCNadia Casado
Nadia Casado
CPCovadonga Perez
Covadonga Perez
Carmina Gallardo FrontauraCarmina Gallardo Frontaura
Carmina Gallardo Frontaura
Candidate vaccines against African swine fever virus (ASFV) based on naturally attenuated or genetically modified viruses have the potential to generate protective immune responses, although there is no consensus on what defines a protective immune response against ASFV. Studies, espe-cially in sensible host species, focused on unravelling protective mechanisms will contribute to the development of safer and more effective vaccines. The present study provides a detailed analysis of phenotypic and functional data on cellular responses induced by intradermal immunization and subsequent boosting of domestic pigs with the naturally attenuated field strain Lv17/WB/Rie1, as well as the mechanisms underlying protection against intramuscular challenge with the virulent genotype II Armenia/07 strain. The transient mild to moderate increase of IL-8 and IL-10 in serum observed after immunization might be directly correlated with survival. Protection was also associated with a robust ASFV-specific polyfunctional memory T cell response, where CD4CD8 and CD8 T cells were identified as the main cellular sources of virus-specific IFNγ and TNFα. In parallel to cytokine response, these T-cell subsets also showed specific cytotoxic activity as evidenced by the increased expression of the CD107a degranulation marker. Along with virus-specific multifunctional CD4CD8 and CD8 T responses, the increased levels of antigen experienced cytotoxic CD4 T cells observed after challenge in immunized pigs might also contribute to control virulent infection by killing mechanisms targeting infected antigen-presenting cells. Future studies should elucidate whether the memory T-cell responses evidenced in the present study persist and provide long-term protection against further ASFV infections.

25 March 2014
Verified
Book Chapter
Closed access
CANO GÓMEZ CRISTINACANO GÓMEZ CRISTINA
CANO GÓMEZ CRISTINA
PLPaloma Fernández-Pacheco López-Amor
Paloma Fernández-Pacheco López-Amor
Miguel Angel Jimenez-ClaveroMiguel Angel Jimenez-Clavero
Miguel Angel Jimenez-Clavero